Literature DB >> 29627775

Acute mucocutaneous methotrexate toxicity with marked tissue eosinophilia.

Luis J Borda1, Andrew Ross1, Gabriel Villada1, Clara Milikowski2.   

Abstract

Methotrexate toxicity in mucocutaneous areas is usually not associated with tissue eosinophilia. We describe a case of acute methotrexate-induced mucocutaneous erosions with interface dermatitis and eosinophils. A 76-year-old African-American woman with a history of bullous pemphigoid on methotrexate therapy presented with lower extremity cellulitis, developing oral and cutaneous erosions during hospitalization after daily dosage of methotrexate. Shallow circular cutaneous erosions were found on chest, abdomen and limbs. Laboratory results showed pancytopaenia and elevated liver function tests. Skin biopsy revealed irregular acanthotic epidermis with interface dermatitis, individual dyskeratotic cells and superficial perivascular lymphocytic infiltrate with numerous eosinophils. Methotrexate was stopped and leucovorin was administered, leading to improvement. The histopathological changes in acute mucocutaneous toxicity range from pauci-inflammatory erosions with dyskeratotic keratinocytes to interface dermatitis and infrequently seen eosinophils. This case exemplifies that interface dermatitis with a marked eosinophilic infiltrate can be found in the setting of acute mucocutaneous methotrexate toxicity. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  eosinophilic infiltrate; interface dermatitis; methotrexate toxicity; mucocutaneous erosions

Mesh:

Substances:

Year:  2018        PMID: 29627775      PMCID: PMC5893949          DOI: 10.1136/bcr-2017-221489

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Methotrexate toxicity presenting as ulcerated psoriatic plaques.

Authors:  Su-ming Wong; Yew Thong Chong; Suganthi Thevarajah; Roshidah Baba
Journal:  Australas J Dermatol       Date:  2011-06-09       Impact factor: 2.875

2.  Erosion of psoriatic plaques after chronic methotrexate administration.

Authors:  D L Kaplan; E A Olsen
Journal:  Int J Dermatol       Date:  1988 Jan-Feb       Impact factor: 2.736

3.  Bullous pemphigoid: a case series with emphasis on long-term remission off therapy.

Authors:  Shawn G Kwatra; Joseph L Jorizzo
Journal:  J Dermatolog Treat       Date:  2012-03-04       Impact factor: 3.359

4.  Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis.

Authors:  E J Primka; C Camisa
Journal:  J Am Acad Dermatol       Date:  1997-05       Impact factor: 11.527

Review 5.  Methotrexate guidelines--revised.

Authors:  H H Roenigk; R Auerbach; H I Maibach; G D Weinstein
Journal:  J Am Acad Dermatol       Date:  1982-02       Impact factor: 11.527

6.  Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease.

Authors:  N Hani; C Casper; W Groth; T Krieg; N Hunzelmann
Journal:  Eur J Dermatol       Date:  2000 Oct-Nov       Impact factor: 3.328

7.  Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.

Authors:  Julie L Fridlington; Julia W Tripple; Jason S Reichenberg; Clifton S Hall; Dayna G Diven
Journal:  Dermatol Online J       Date:  2011-11-15

8.  Acute mucocutaneous methotrexate toxicity associated with interface dermatitis and numerous eosinophils.

Authors:  Nkanyezi N Ferguson; Adam Asarch; Marta VanBeek; Brian L Swick
Journal:  Am J Dermatopathol       Date:  2013-06       Impact factor: 1.533

9.  Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.

Authors:  Robert E Kalb; Bruce Strober; Gerald Weinstein; Mark Lebwohl
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

10.  Mucocutaneous ulcerations secondary to methotrexate.

Authors:  Jennifer Warner; Alissa Brown; S Elizabeth Whitmore; David A Cowan
Journal:  Cutis       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.